Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Many people associate psoriatic arthritis (PsA) with itchy, scaly skin and joint pain, but excess fatigue is also a symptom for at least 50% of people with PsA. Fatigue from PsA might be mild ...

Scientists are urging quicker diagnosis and treatment of psoriatic arthritis to prevent long-term harm to patients. Psoriatic ...

Psoriatic arthritis can affect any joint in the body, including the elbow. When joints are affected, symptoms may resemble other types of arthritis. Inflammatory arthritis happens when the immune ...

Psoriatic arthritis (PsA) is an immune-mediated condition, and people with PsA may be at a higher risk of developing many neurological conditions. Psoriatic arthritis (PsA) is an immune-mediated ...

A new study explores gaps in how patients and physicians view psoriatic arthritis (PsA) and recommends ways for clinicians to ...

Delays in diagnosing and treating psoriatic arthritis – a common inflammatory disorder affecting 112 in every 100,000 adults – are causing irreparable ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...